Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FDZVG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,836
Award facts
- Contract value 100% obligated
- $32,835.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded March 19, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units with a ceiling value of $32,835.75. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. RINVOQ (upadacitinib) is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, supporting the federal healthcare supply chain's medical requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's significant contract portfolio and demonstrated capability to fulfill federal medical procurement requirements through open competition position it as a critical vendor within the DLA's pharmaceutical supply network.
Quick answers
Who was awarded contract SPE2DB25FDZVG?
SPE2DB25FDZVG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 19, 2025.
How much is contract SPE2DB25FDZVG worth?
The government has obligated $32,836 on SPE2DB25FDZVG.
Is contract SPE2DB25FDZVG an order under another contract?
Yes. SPE2DB25FDZVG is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FDZVG competed?
The extent of competition for SPE2DB25FDZVG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award